查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1965363

血液学市场－全球产业规模、份额、趋势、机会、预测：试剂、产品、地区和竞争格局（2021-2031年）

Hematology Market - Global Industry Size, Share, Trends, Opportunity, & Forecast Segmented By Reagent, By Product, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球血液学市场预计将从 2025 年的 180.2 亿美元成长到 2031 年的 254.1 亿美元，复合年增长率为 5.89%。

该市场涵盖医疗机构用于检测、分析和监测血液疾病的专用诊断设备、试剂和耗材。该领域的成长主要受白血病和贫血等血液疾病发病率上升以及全球人口老化导致持续诊断监测需求增加的驱动。此外，临床检查室对高通量检测的需求也推动了对自动化解决方案的持续需求，以确保为关键患者照护提供快速检测结果。

市场概览
预测期 2027-2031
市场规模：2025年 180.2亿美元
市场规模：2031年 254.1亿美元
复合年增长率：2026-2031年 5.89%
成长最快的细分市场 凝血试剂
最大的市场 北美洲

美国癌症协会在其2025年报告中强调了建立健全诊断基础设施的迫切需求，并指出「预计美国白血病、淋巴瘤或骨髓瘤的确诊患者总合将达到192,070人」。儘管有这些强劲的驱动因素，市场仍面临一个重大障碍：先进血液分析仪的高昂购买成本。这种经济负担限制了小规模医疗机构和新兴经济体采用这些仪器的普及率，构成了一项可能阻碍市场更广泛扩张的重大挑战。

市场驱动因素

人工智慧 (AI) 与数位病理学的融合正在从根本上改变全球血液学市场，优化诊断准确性和工作流程效率。检查室正越来越多地采用能够自动识别和分类血球的 AI 演算法，从而显着减少人工显微镜检查所需的时间。这项技术变革不仅解决了熟练血液科医生严重短缺的问题，还最大限度地减少了复杂诊断中的人为错误。例如，Scopio Labs 在 2025 年 7 月的新闻稿中宣布推出其 AI 驱动的「全血形态学」分析仪。这是第一个能够完全自动化血球分析的解决方案，无需人工检测，并迅速将数位血液学确立为行业标准。

同时，临床检测量激增的需求正在加速自动化高通量血液分析仪的普及应用。大型检查室优先引进模组化自动化系统，将血液学检测与其他领域整合，以提高营运效率并缩短结果报告时间。全球血液疾病带来的巨大负担进一步加剧了这项需求。例如，世界卫生组织（世卫组织）于2025年8月发布的《2025年全球贫血估计值：主要发现》报告显示，到2023年，全球15至49岁女性中约有30.7%将患有贫血，需要持续的诊断监测。为了反映这项需求的激增，希森美康公司于2025年5月发布的《截至2025年3月的财政年度概要》报告称，其全球合併销售额增长了10.2%，主要得益于血液学领域仪器和试剂销售额的增长。

市场挑战

先进的血液分析仪需要大量的资金投入，这成为市场成长的主要障碍，尤其是在资源匮乏的环境中。这些诊断系统凭藉其自动化和高通量功能，价格昂贵，往往令小规模诊所、区域医疗中心和新兴经济体的医疗机构难以负担。因此，相当一部分潜在客户无法从手动或半自动方法过渡到全自动解决方案，阻碍了现代血液学技术的应用，并限制了整体市场扩张。

这种财务压力正直接影响医疗保健产业的采购行为和采购週期。预算限制迫使许多医疗机构延长现有设备的使用寿命，而不是投资新设备。美国医院协会预测，到2025年，94%的医疗机构管理者将推迟设备升级以应对财务负担，这印证了上述限制。这种普遍推迟购置资本设备的趋势降低了旧有系统的更换速度，并导致全球血液学领域製造商的产生收入显着下降。

市场趋势

受重症监护领域对快速诊断需求的推动，全球血液学市场正向分散式和照护现场(POC) 解决方案转型。这一趋势包括携带式分析仪的推出，这些分析仪可在传统实验室之外提供实验室级别的全血细胞计数，从而加速临床检验。製造商正积极验证这些平台，以满足严格的监管标准。例如，PixCell Medical 在 2024 年 11 月的新闻稿中宣布，其 HemoScreen CBC 分析仪已成为首款获得欧盟体外医疗设备法规 (IVDR) 认证的照护现场五类分析仪，证明了其在各种医疗环境中的实用性。

同时，个人化血液学诊断的兴起正在透过将基因组分析与常规评估相结合，改变血液肿瘤的治疗方式。医疗机构正在利用分子诊断来识别基因突变，从而实现针对急性骨髓性白血病(AML) 等疾病的标靶治疗。这种方法透过根据疾病的生物学特征量身定制治疗方案，改善了治疗效果。例如，根据白血病和淋巴瘤协会 2024 年 11 月发布的新闻稿《ASH 数据展望血液肿瘤治疗的未来》，约有 1600 名 AML 患者在确诊后七天内接受了基因组筛检，加速了精准治疗的实现。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球血液学市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 试剂类型（凝血试剂、流式细胞技术试剂、免疫血液学试剂、其他）
    • 副产物（血液分析仪、流式细胞仪、凝血分析仪、玻片染色仪）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美血液学市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲血液学市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太血液学市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲血液学市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲血液学市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球血液学市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Abbott Laboratories Inc.
  • F. Hoffmann-La Roche Ltd
  • Sysmex Corporation
  • Siemens Healthineers AG
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Boule Diagnostics AB
  • Nihon Kohden Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Diatron Medical Instruments Limited

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 24323

The Global Hematology Market is projected to expand from USD 18.02 Billion in 2025 to USD 25.41 Billion by 2031, achieving a CAGR of 5.89%. This market encompasses specialized diagnostic instruments, reagents, and consumables utilized by healthcare providers to detect, analyze, and monitor blood disorders. The sector's growth is primarily driven by the rising prevalence of hematologic diseases, such as leukemia and anemia, alongside an aging global population that requires consistent diagnostic oversight. Additionally, the necessity for high-throughput testing in clinical laboratories fuels a steady demand for automated solutions to ensure faster turnaround times for critical patient care.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 18.02 Billion
Market Size 2031USD 25.41 Billion
CAGR 2026-20315.89%
Fastest Growing SegmentCoagulation Reagents
Largest MarketNorth America

Underscoring the urgent need for robust diagnostic infrastructure, the 'American Cancer Society' reported in '2025' that 'an estimated combined total of 192,070 people in the US are expected to be diagnosed with leukemia, lymphoma or myeloma'. Despite these strong drivers, the market faces a significant obstacle regarding the high capital costs associated with advanced hematology analyzers. This financial burden limits adoption rates among smaller healthcare facilities and within emerging economies, presenting a considerable challenge that could hinder broader market expansion.

Market Driver

The integration of Artificial Intelligence and digital pathology is fundamentally reshaping the Global Hematology Market by optimizing diagnostic precision and workflow efficiency. Laboratories are increasingly implementing AI algorithms that automatically identify and classify blood cells, which significantly reduces the time required for manual microscopic reviews. This technological shift addresses the critical shortage of skilled hematopathologists while minimizing human error in complex diagnoses. Validating this advancement, according to Scopio Labs, July 2025, in a company press release, the firm unveiled its AI-powered Complete Blood Morphology analyzer, a first-of-its-kind solution designed to fully automate the analysis of blood cells and eliminate the need for manual review, rapidly establishing digital hematology as a standard of care.

Simultaneously, the expansion of automated high-throughput hematology analyzers is being propelled by the urgent necessity to manage escalating testing volumes in clinical settings. High-volume laboratories are prioritizing modular automation tracks that integrate hematology with other disciplines to streamline operations and improve turnaround times. This demand is further amplified by the immense global burden of blood disorders; for instance, according to the World Health Organization, August 2025, in the 'WHO global anaemia estimates: key findings, 2025', approximately 30.7% of women aged 15-49 years worldwide suffered from anemia in 2023, necessitating consistent diagnostic monitoring. Reflecting this surge in demand, according to Sysmex Corporation, May 2025, in the 'Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2025', global consolidated net sales increased by 10.2%, driven significantly by higher sales of instruments and reagents in the hematology field.

Market Challenge

The high capital investment required for advanced hematology analyzers constitutes a primary barrier to market growth, particularly in resource-constrained settings. These diagnostic systems, which offer automated and high-throughput capabilities, command premium prices that are often prohibitive for smaller clinics, community health centers, and facilities in emerging economies. Consequently, a significant portion of the potential customer base is unable to transition from manual or semi-automated methods to fully automated solutions, thereby stifling the broader adoption of modern hematology technologies and limiting overall market expansion.

This financial pressure directly impacts purchasing behaviors and procurement cycles within the healthcare sector. Budgetary constraints force many institutions to extend the lifespan of existing equipment rather than investing in newer models. Validating this constraint, according to 'American Hospital Association', in '2025', '94% of health care administrators expect to delay equipment upgrades to manage financial strain'. This widespread deferral of capital equipment acquisition slows the replacement rate of legacy systems and creates a measurable deceleration in revenue generation for manufacturers operating in the global hematology space.

Market Trends

The Global Hematology Market is shifting toward decentralized and point-of-care (POC) testing solutions, driven by the demand for rapid diagnostics in critical care. This trend involves deploying portable analyzers that deliver lab-quality complete blood counts outside traditional laboratories, accelerating clinical decision-making. Manufacturers are actively validating these platforms to meet rigorous regulatory standards. Validating this maturity, according to PixCell Medical, November 2024, in a company press release, its HemoScreen CBC analyzer became the first point-of-care 5-part differential analyzer to achieve certification under the EU's In Vitro Diagnostic Medical Devices Regulation (IVDR), confirming its readiness for diverse healthcare environments.

Concurrently, the rise of personalized hematology diagnostics is transforming blood cancer management by integrating genomic profiling with routine evaluation. Providers are adopting molecular diagnostics to identify genetic mutations, enabling targeted therapies for conditions like acute myeloid leukemia (AML). This approach improves outcomes by tailoring treatment to the disease's biological signature. Highlighting this adoption, according to The Leukemia & Lymphoma Society, November 2024, in the 'Data at ASH Provides Glimpse into the Future of Blood Cancer Treatment' press release, nearly 1,600 patients with AML have received genomic screening within seven days of diagnosis to facilitate precision treatment.

Key Market Players

  • Abbott Laboratories Inc.
  • F. Hoffmann-La Roche Ltd
  • Sysmex Corporation
  • Siemens Healthineers AG
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Boule Diagnostics AB
  • Nihon Kohden Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Diatron Medical Instruments Limited

Report Scope

In this report, the Global Hematology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hematology Market, By Reagent

  • Coagulation Reagents
  • Flow Cytometry Reagents
  • Immuno-hematology Reagents
  • Other

Hematology Market, By Product

  • Hematology Analyzers
  • Flow Cytometers
  • Coagulation Analyzers
  • Slide Stainers

Hematology Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hematology Market.

Available Customizations:

Global Hematology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hematology Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Reagent (Coagulation Reagents, Flow Cytometry Reagents, Immuno-hematology Reagents, Other)
    • 5.2.2. By Product (Hematology Analyzers, Flow Cytometers, Coagulation Analyzers, Slide Stainers)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Hematology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Reagent
    • 6.2.2. By Product
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Hematology Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Reagent
        • 6.3.1.2.2. By Product
    • 6.3.2. Canada Hematology Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Reagent
        • 6.3.2.2.2. By Product
    • 6.3.3. Mexico Hematology Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Reagent
        • 6.3.3.2.2. By Product

7. Europe Hematology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Reagent
    • 7.2.2. By Product
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Hematology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Reagent
        • 7.3.1.2.2. By Product
    • 7.3.2. France Hematology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Reagent
        • 7.3.2.2.2. By Product
    • 7.3.3. United Kingdom Hematology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Reagent
        • 7.3.3.2.2. By Product
    • 7.3.4. Italy Hematology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Reagent
        • 7.3.4.2.2. By Product
    • 7.3.5. Spain Hematology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Reagent
        • 7.3.5.2.2. By Product

8. Asia Pacific Hematology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Reagent
    • 8.2.2. By Product
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Hematology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Reagent
        • 8.3.1.2.2. By Product
    • 8.3.2. India Hematology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Reagent
        • 8.3.2.2.2. By Product
    • 8.3.3. Japan Hematology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Reagent
        • 8.3.3.2.2. By Product
    • 8.3.4. South Korea Hematology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Reagent
        • 8.3.4.2.2. By Product
    • 8.3.5. Australia Hematology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Reagent
        • 8.3.5.2.2. By Product

9. Middle East & Africa Hematology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Reagent
    • 9.2.2. By Product
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Hematology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Reagent
        • 9.3.1.2.2. By Product
    • 9.3.2. UAE Hematology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Reagent
        • 9.3.2.2.2. By Product
    • 9.3.3. South Africa Hematology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Reagent
        • 9.3.3.2.2. By Product

10. South America Hematology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Reagent
    • 10.2.2. By Product
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Hematology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Reagent
        • 10.3.1.2.2. By Product
    • 10.3.2. Colombia Hematology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Reagent
        • 10.3.2.2.2. By Product
    • 10.3.3. Argentina Hematology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Reagent
        • 10.3.3.2.2. By Product

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Hematology Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. F. Hoffmann-La Roche Ltd
  • 15.3. Sysmex Corporation
  • 15.4. Siemens Healthineers AG
  • 15.5. Danaher Corporation
  • 15.6. Bio-Rad Laboratories, Inc.
  • 15.7. Boule Diagnostics AB
  • 15.8. Nihon Kohden Corporation
  • 15.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 15.10. Diatron Medical Instruments Limited

16. Strategic Recommendations

17. About Us & Disclaimer